交易 Krystal Biotech, Inc. - KRYS CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.96 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
Krystal Biotech Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Mar 27, 2024 | 176.76 | 2.38 | 1.36% | 174.38 | 180.04 | 172.15 |
Mar 26, 2024 | 173.88 | 4.48 | 2.64% | 169.40 | 176.60 | 169.40 |
Mar 25, 2024 | 168.84 | 1.15 | 0.69% | 167.69 | 171.25 | 166.00 |
Mar 22, 2024 | 167.10 | 1.55 | 0.94% | 165.55 | 170.49 | 165.55 |
Mar 21, 2024 | 169.53 | 0.16 | 0.09% | 169.37 | 174.99 | 167.06 |
Mar 20, 2024 | 171.15 | 5.26 | 3.17% | 165.89 | 171.46 | 163.55 |
Mar 19, 2024 | 166.64 | -1.80 | -1.07% | 168.44 | 173.03 | 166.12 |
Mar 18, 2024 | 168.43 | 0.44 | 0.26% | 167.99 | 171.76 | 165.45 |
Mar 15, 2024 | 172.92 | 2.99 | 1.76% | 169.93 | 174.07 | 166.58 |
Mar 14, 2024 | 171.61 | -3.30 | -1.89% | 174.91 | 176.68 | 168.85 |
Mar 13, 2024 | 179.21 | 0.31 | 0.17% | 178.90 | 181.38 | 174.99 |
Mar 12, 2024 | 178.81 | 11.41 | 6.82% | 167.40 | 180.10 | 167.40 |
Mar 11, 2024 | 170.16 | -1.59 | -0.93% | 171.75 | 174.63 | 167.40 |
Mar 8, 2024 | 171.70 | 2.81 | 1.66% | 168.89 | 175.31 | 166.02 |
Mar 7, 2024 | 169.34 | -4.99 | -2.86% | 174.33 | 175.54 | 168.43 |
Mar 6, 2024 | 174.25 | 2.36 | 1.37% | 171.89 | 177.09 | 169.89 |
Mar 5, 2024 | 170.73 | 4.84 | 2.92% | 165.89 | 188.16 | 165.89 |
Mar 4, 2024 | 159.84 | -9.56 | -5.64% | 169.40 | 170.09 | 159.10 |
Mar 1, 2024 | 167.71 | 8.41 | 5.28% | 159.30 | 169.30 | 159.30 |
Feb 29, 2024 | 159.36 | -4.80 | -2.92% | 164.16 | 165.53 | 155.52 |
Krystal Biotech, Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Monday, May 6, 2024 | ||
時間 (UTC) 12:30 | 國家 US
| 事件 Q1 2024 Krystal Biotech Inc Earnings Release Q1 2024 Krystal Biotech Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, May 17, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Krystal Biotech Inc Annual Shareholders Meeting Krystal Biotech Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | |||||
總營業費用 | 145.196 | 68.275 | 32.999 | 22.081 | 11.916 |
銷售/一般/行政費用,總計 | 77.735 | 40.391 | 15.063 | 6.465 | 4.155 |
研究與開發 | 42.461 | 27.884 | 17.936 | 15.616 | 7.761 |
營業收入 | -145.196 | -68.275 | -32.999 | -22.081 | -11.916 |
利息收入(費用),非經營淨值 | 5.221 | -1.295 | 0.832 | 2.993 | 1.027 |
稅前淨收入 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
稅後淨收入 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
未計算非常項目前的淨收益 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
淨收入 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
普通股股東可獲收益 (不含非經常性項目) | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
普通股股東可獲收益 (含非經常性項目) | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
攤薄調整 | |||||
攤薄淨收入 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
攤薄後加權平均股 | 25.4917 | 22.1968 | 18.7872 | 15.9011 | 11.2031 |
扣除特別項目的每股攤薄盈利 | -5.491 | -3.13423 | -1.71218 | -1.20042 | -0.97196 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常攤薄盈利 | -4.51029 | -3.13423 | -1.71218 | -1.20042 | -0.97196 |
非常規項目總計 | 0 | ||||
Total Adjustments to Net Income | 0 | ||||
異常費用(收入) | 25 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
總營業費用 | 38.048 | 48.823 | 34.771 | 31.451 | 28.753 |
銷售/一般/行政費用,總計 | 25.904 | 24.035 | 24.03 | 19.935 | 17.863 |
研究與開發 | 12.144 | 12.288 | 10.741 | 11.516 | 10.89 |
營業收入 | -38.048 | -48.823 | -34.771 | -31.451 | -28.753 |
利息收入(費用),非經營淨值 | 4.838 | 3.526 | 2.719 | 1.601 | 0.645 |
稅前淨收入 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
稅後淨收入 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
未計算非常項目前的淨收益 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
淨收入 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
普通股股東可獲收益 (不含非經常性項目) | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
普通股股東可獲收益 (含非經常性項目) | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
攤薄淨收入 | -33.21 | -45.297 | -32.052 | -29.85 | -28.108 |
攤薄後加權平均股 | 26.6569 | 25.7122 | 25.6826 | 25.6191 | 25.5452 |
扣除特別項目的每股攤薄盈利 | -1.24583 | -1.76169 | -1.248 | -1.16515 | -1.10033 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -1.24583 | -1.27554 | -1.248 | -1.16515 | -1.10033 |
異常費用(收入) | 0 | 12.5 | 0 | 0 | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 383.779 | 442.267 | 275.058 | 195.88 | 112.65 |
現金和短期投資 | 379.171 | 438.096 | 271.262 | 193.685 | 111.761 |
現金等價物 | 161.9 | 341.246 | 268.269 | 187.514 | 103.67 |
預付的費用 | 4.608 | 4.171 | 3.796 | 2.195 | 0.889 |
其他流動資産,總計 | |||||
總資産 | 558.45 | 626.295 | 310.844 | 209.023 | 116.116 |
物業/廠房/設備,總計 - 淨額 | 169.726 | 119.583 | 34.174 | 11.184 | 3.014 |
物業/廠房/設備,總計 - 總額 | 176.519 | 123.797 | 36.542 | 12.034 | 3.18 |
累計折舊,總計 | -6.793 | -4.214 | -2.368 | -0.85 | -0.166 |
流動負債總額 | 28.847 | 25.736 | 15.452 | 3.327 | 2.596 |
應付賬款 | 3.981 | 8.398 | 2.105 | 0.724 | 0.888 |
預提費用 | 24.556 | 17.168 | 5.681 | 2.544 | 1.515 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | |||||
負債總額 | 36.219 | 32.719 | 18.76 | 6.109 | 2.89 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | |||||
其他負債,總計 | 7.372 | 6.983 | 3.308 | 2.782 | 0.294 |
股權 | 522.231 | 593.576 | 292.084 | 202.914 | 113.226 |
Redeemable Preferred Stock | 0 | 0 | |||
普通股 | 0.00026 | 0.003 | 0.0002 | 0.00017 | 0 |
額外實收資本 | 803.718 | 734.523 | 363.292 | 241.951 | 133.183 |
留存收益(累計赤字) | -280.759 | -140.787 | -71.214 | -39.047 | -19.959 |
總負債和股東權益 | 558.45 | 626.295 | 310.844 | 209.023 | 116.116 |
已發行普通股總數 | 25.7637 | 25.208 | 19.7142 | 17.3543 | 14.4289 |
其他流動負債,總計 | 0.31 | 0.17 | 7.666 | 0.059 | 0.193 |
短期投資 | 217.271 | 96.85 | 2.993 | 6.171 | 8.091 |
其他長期資産,總計 | 0.324 | 0.074 | 1.612 | 1.462 | 0.452 |
其他權益,總計 | -0.72826 | -0.163 | 0.0058 | 0.00983 | 0.002 |
長期投資 | 4.621 | 64.371 | 0 | 0.497 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 582.128 | 484.004 | 355.429 | 383.779 | 397.578 |
現金和短期投資 | 562.069 | 477.517 | 350.387 | 379.171 | 394.42 |
現金等價物 | 373.241 | 275.875 | 140.745 | 161.9 | 186.409 |
短期投資 | 188.828 | 201.642 | 209.642 | 217.271 | 208.011 |
預付的費用 | 5.465 | 6.487 | 5.042 | 4.608 | 3.158 |
總資産 | 790.35 | 684.026 | 531.847 | 558.45 | 576.379 |
物業/廠房/設備,總計 - 淨額 | 171.389 | 171.327 | 170.887 | 169.726 | 166.039 |
物業/廠房/設備,總計 - 總額 | 182.128 | 180.471 | 178.773 | 176.519 | 171.84 |
累計折舊,總計 | -10.739 | -9.144 | -7.886 | -6.793 | -5.801 |
其他長期資産,總計 | 0.285 | 0.285 | 0.402 | 0.324 | 0.205 |
流動負債總額 | 27.583 | 23.898 | 35.076 | 28.847 | 28.032 |
應付賬款 | 4.34 | 4.446 | 4.109 | 3.981 | 5.761 |
預提費用 | 20.776 | 18.778 | 30.595 | 24.556 | 21.681 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 2.467 | 0.674 | 0.372 | 0.31 | 0.59 |
負債總額 | 34.402 | 30.912 | 42.281 | 36.219 | 35.607 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 6.819 | 7.014 | 7.205 | 7.372 | 7.575 |
股權 | 755.948 | 653.114 | 489.566 | 522.231 | 540.772 |
Preferred Stock - Non Redeemable, Net | 0 | ||||
普通股 | 0.00028 | 0.00028 | 0.00026 | 0.00026 | 0.00026 |
額外實收資本 | 1034.85 | 1012.62 | 815.776 | 803.718 | 790.954 |
留存收益(累計赤字) | -278.519 | -359.266 | -326.056 | -280.759 | -248.707 |
其他權益,總計 | -0.38228 | -0.23628 | -0.15426 | -0.72826 | -1.47526 |
總負債和股東權益 | 790.35 | 684.026 | 531.847 | 558.45 | 576.379 |
已發行普通股總數 | 28.1947 | 27.9749 | 25.7962 | 25.7637 | 25.7097 |
長期投資 | 36.548 | 28.41 | 5.129 | 4.621 | 12.557 |
應收賬款總額,淨額 | 9.316 | ||||
應收賬款 - 貿易,淨額 | 9.316 | ||||
總庫存 | 5.278 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -139.975 | -69.57 | -32.167 | -19.088 | -10.889 |
經營活動産生的現金 | -100.569 | -47.938 | -26.083 | -18.69 | -9.445 |
經營活動産生的現金 | 4.055 | 2.769 | 1.851 | 1.09 | 0.141 |
非現金物品 | 32.54 | 16.811 | 3.305 | 1.306 | 0.792 |
Cash Taxes Paid | |||||
已付現金利息 | |||||
營運資金的變化 | 2.811 | 2.052 | 0.928 | -1.998 | 0.511 |
投資活動産生的現金 | -114.083 | -226.77 | -11.181 | -4.991 | -10.323 |
資本支出 | -52.979 | -68.336 | -14.843 | -6.399 | -2.234 |
融資活動産生的現金 | 35.347 | 347.685 | 118.019 | 107.525 | 73.847 |
股票的發行(報廢),淨額 | 35.996 | 355.645 | 118.019 | 107.525 | 73.847 |
債務的發行(退還),淨額 | 0 | ||||
現金淨變化 | -179.346 | 72.977 | 80.755 | 83.844 | 54.079 |
其他投資現金流量項目,總計 | -61.104 | -158.434 | 3.662 | 1.408 | -8.089 |
融資現金流項目 | -0.649 | -7.96 | |||
外彙效應 | -0.041 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -45.297 | -139.975 | -107.923 | -78.073 | -49.965 |
Cash From Operating Activities | -26.156 | -100.569 | -78.24 | -58.552 | -15.493 |
Cash From Operating Activities | 0.705 | 4.055 | 2.966 | 1.991 | 1.015 |
Non-Cash Items | 9.832 | 32.54 | 23.476 | 14.453 | 6.295 |
Changes in Working Capital | 8.604 | 2.811 | 3.241 | 3.077 | 27.162 |
Cash From Investing Activities | 3.563 | -114.083 | -108.875 | -94.132 | -55.908 |
Capital Expenditures | -5.381 | -52.979 | -47.762 | -33.706 | -17.191 |
Other Investing Cash Flow Items, Total | 8.944 | -61.104 | -61.113 | -60.426 | -38.717 |
Cash From Financing Activities | 1.474 | 35.347 | 32.278 | 30.158 | -0.542 |
Financing Cash Flow Items | -0.749 | -0.649 | -0.649 | -0.649 | -0.649 |
Issuance (Retirement) of Stock, Net | 2.223 | 35.996 | 32.927 | 30.807 | 0.107 |
Net Change in Cash | -21.155 | -179.346 | -154.837 | -122.526 | -71.943 |
Foreign Exchange Effects | -0.036 | -0.041 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
2100 Wharton St Ste 701
PITTSBURGH
PENNSYLVANIA 15203
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 580.000 多名交易者,選擇與 Capital.com 交易